Replies to post #116764 on Savvy Trades and Investments

[researcher59]

MD (12.32) reports strong Q3 results - adj EPS of $0.44

briefing -

Pediatrix Medical Group beats by $0.07, beats on revs (12.32 ) :
Reports Q3 (Sep) earnings of $0.44 per share, excluding non-recurring items, $0.07 better than the FactSet Consensus of $0.37; revenues rose 0.9% year/year to $511.2 mln vs the $498.87 mln FactSet Consensus.
2024 Outlook
Pediatrix anticipates that its 2024 Adjusted EBITDA, as defined above, will be in a range of $205 million to $215 million. This outlook reflects Adjusted EBITDA for the first nine months of 2024 of $155.3 million.